Diclox Patch 30ct System
Product Images NDC 87234-0405

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diclox Patch 30ct (NDC 87234-0405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Injecta Medcial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

526d2a57 7f63 2ca2 E063 6394a90ae710

The packaging label for Diclox Patch 30CT features diclofenac epolamine topical system 1.3%. The label includes dosage form as a topical system with 30 patches, each measuring 10 cm by 14 cm. It provides directions illustrated for proper use and instructions to change the patch every 12 hours. The labeler is Injecta Medical LLC and the product is for prescription use only.*

FDA Label Image

Chemical Structure (Chemical Structure Diclo)

Chemical structure of the active ingredient Diclofenac Epolamine, showing the molecular configurations of Diclofenac and Epolamine components, including functional groups and atom arrangement.*

FDA Label Image

Clinical Studies (Clinical Studies Diclo)

Four line graphs showing percent of patients improved versus percent improvement from baseline in studies assessing pain relief with Diclofenac Epolamine 1.3% Patch versus placebo. The graphs correspond to Day 3 and end of study time points for 14-day and 7-day studies with labeled data points differentiating Diclofenac Patch from placebo results.*

FDA Label Image

Package (Diclofenac Patch 87234040503 30ct)

The image shows the packaging label for Diclox Patch 30CT, containing diclofenac epolamine topical system 1.3%. It is a topical system with 30 patches, each 10 cm x 14 cm, indicated for prescription use. The label includes application instructions with illustrations, warnings, and directions. Manufactured by Injecta Medical LLC, the label also features the NDC 87234-0405.*

FDA Label Image

Adverse Reactions (Table 1 Diclof)

Table showing common adverse events occurring in 1% or more of patients treated with Diclofenac Epolamine Topical System 1.3% or placebo. The table categorizes events by body system—application site conditions, gastrointestinal disorders, nervous system disorders—and lists number and percentage of occurrences in Diclofenac and placebo groups, including specific conditions like pruritus, nausea, headache, and others.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.